You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Radiotherapy and "new" drugs-new side effects?
|
|---|---|
| Published in |
Radiation Oncology, December 2011
|
| DOI | 10.1186/1748-717x-6-177 |
| Pubmed ID | |
| Authors |
Maximilian Niyazi, Cornelius Maihoefer, Mechthild Krause, Claus Rödel, Wilfried Budach, Claus Belka |
| Abstract |
Targeted drugs have augmented the cancer treatment armamentarium. Based on the molecular specificity, it was initially believed that these drugs had significantly less side effects. However, currently it is accepted that all of these agents have their specific side effects. Based on the given multimodal approach, special emphasis has to be placed on putative interactions of conventional cytostatic drugs, targeted agents and other modalities. The interaction of targeted drugs with radiation harbours special risks, since the awareness for interactions and even synergistic toxicities is lacking. At present, only limited is data available regarding combinations of targeted drugs and radiotherapy. This review gives an overview on the current knowledge on such combined treatments. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 50% |
| Unknown | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 123 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 2% |
| Portugal | 1 | <1% |
| Germany | 1 | <1% |
| Italy | 1 | <1% |
| Unknown | 118 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 24 | 20% |
| Student > Ph. D. Student | 15 | 12% |
| Student > Master | 14 | 11% |
| Other | 12 | 10% |
| Student > Bachelor | 10 | 8% |
| Other | 27 | 22% |
| Unknown | 21 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 57 | 46% |
| Agricultural and Biological Sciences | 14 | 11% |
| Nursing and Health Professions | 5 | 4% |
| Biochemistry, Genetics and Molecular Biology | 4 | 3% |
| Engineering | 4 | 3% |
| Other | 9 | 7% |
| Unknown | 30 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 January 2012.
All research outputs
#14,141,940
of 22,660,862 outputs
Outputs from Radiation Oncology
#803
of 2,041 outputs
Outputs of similar age
#153,036
of 243,043 outputs
Outputs of similar age from Radiation Oncology
#8
of 26 outputs
Altmetric has tracked 22,660,862 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,041 research outputs from this source. They receive a mean Attention Score of 2.7. This one has gotten more attention than average, scoring higher than 56% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 243,043 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 35th percentile – i.e., 35% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.